Skip to main content

Table 2 Difference in cell surface markers from mesenchymal stem cells exploited in clinical trials

From: Immunomodulatory effects of mesenchymal stem cell therapy in chronic kidney disease: a literature review

Trials

Positive

Negative

 

CD29

CD73

CD90

CD105

CD44

CD45

CD34

CD11b

CD14

CD79

HLA-DR

Bone Marrow

Liang,2010 [24]

Wang,2013 [26]

Gu,2014 [28]

Makhlough, 2017 [32]

Makhlough, 2018 [34]

Chun,2022 [37]

Perico,2023 [38]

Umbilical Cord

Sun,2010 [23]

Wang,2013 [26]

Wang,2014 [27]

Yuan,2019 [35]

Adipose

Ranjbar,2022 [36]

  1. : positive expression, : negative expression, —: not tested